Dianthus Therapeutics CFO Sells All Direct Shares for $739,000
Dianthus Therapeutics' CFO, Ryan Savitz, sold 8,224 shares of the company's stock for approximately $739,000 on April 9, 2026. The transaction was an option exercise and immediate sale, reducing his direct ownership to zero. The sale was reported in an SEC Form 4 filing.
Tickers: $DNTH
Topics: executive sales option exercise ownership changes SEC filings stock transactions